Skip to main content
. 2012 Dec 11;109(52):21486–21491. doi: 10.1073/pnas.1216016110

Table 1.

Effect of SPP inhibitors on P. yoelii liver-stage parasites

Compound Mean P. yoelli EEF IC50 ± SD, μM HepG2 IC50, μM
Atovaquone 0.0015 ± 0.00090 >10
NITD731 0.0078 ± 0.0018 >10
NITD679 0.047 ± 0.015 >10
LY-411575 0.048 ± 0.032 >10

SPP inhibitor activity was assayed against P. yoelii sporozoites and host HepG2 cells. EEF, exo-erythrocytic form.

HHS Vulnerability Disclosure